DRUG-RESISTANT TUBERCULOSIS

被引:35
作者
RILEY, LW
机构
[1] Division of International Medicine, Cornell University Medical College, New York, NY
关键词
D O I
10.1093/clinids/17.Supplement_2.S442
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multidrug-resistant tuberculosis (MDRTB) is an iatrogenic disease that is emerging as a major infectious disease problem throughout the world. The AIDS pandemic, increased incidence of tuberculosis in populations with easy access to antituberculosis medications, the deterioration of the public health infrastructure, and inadequate training of health care providers in the epidemiology of tuberculosis are some of the factors contributing to the increased incidence of MDRTB. Mortality from MDRTB exceeds 80% in persons infected with human immunodeficiency virus (HIV) but is also high in patients free of HIV. The management of MDRTB is complicated by the lack of methods for rapid detection of resistant strains of Mycobacterium tuberculosis. The risk of infection among close contacts of patients with MDRTB, the probability of the development of active MDRTB after infection, and the likelihood of cure of MDRTB need to be determined quantitatively. Attributable risk estimates for factors associated with MDRTB should be calculated for each community as part of the strategies to prevent MDRTB. Issues regarding chemoprophylaxis in newly infected contacts of MDRTB cases remain unanswered. Basic research on the mechanisms of action of existing antituberculosis drugs may contribute to an understanding of the mechanism of resistance in M. tuberculosis. There is an urgent need to expand the scope of epidemiological, clinical, and laboratory research to address these problems.
引用
收藏
页码:S442 / S446
页数:5
相关论文
共 39 条
[1]   NICOTINAMIDE-ADENINE DINUCLEOTIDE IN TUBERCLE BACILLI EXPOSED TO ISONIAZID [J].
BEKIERKUNST, A .
SCIENCE, 1966, 152 (3721) :525-+
[2]  
BENDOV I, 1987, AM REV RESPIR DIS, V135, P1307
[3]   RESURGENT TUBERCULOSIS IN NEW-YORK-CITY - HUMAN-IMMUNODEFICIENCY-VIRUS, HOMELESSNESS, AND THE DECLINE OF TUBERCULOSIS-CONTROL PROGRAMS [J].
BRUDNEY, K ;
DOBKIN, J .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04) :745-749
[4]   THE BCG CONTROVERSY - A METHODOLOGICAL AND STATISTICAL REAPPRAISAL [J].
CLEMENS, JD ;
CHUONG, JJH ;
FEINSTEIN, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (17) :2362-2369
[5]  
COHN ML, 1954, AM REV TUBERC PULM, V70, P641
[6]   AN OUTBREAK OF TUBERCULOSIS WITH ACCELERATED PROGRESSION AMONG PERSONS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS - AN ANALYSIS USING RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS [J].
DALEY, CL ;
SMALL, PM ;
SCHECTER, GF ;
SCHOOLNIK, GK ;
MCADAM, RA ;
JACOBS, WR ;
HOPEWELL, PC .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04) :231-235
[7]   MULTIDRUG-RESISTANT TUBERCULOSIS [J].
DOOLEY, SW ;
JARVIS, WR ;
MARTONE, WJ ;
SNIDER, DE .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (03) :257-259
[8]  
EDIN BR, 1992, NEW ENGL J MED, V326, P1514
[9]   CLINICAL PRESENTATION AND OUTCOME OF PATIENTS WITH HIV-INFECTION AND TUBERCULOSIS CAUSED BY MULTIPLE-DRUG-RESISTANT BACILLI [J].
FISCHL, MA ;
DAIKOS, GL ;
UTTAMCHANDANI, RB ;
POBLETE, RB ;
MORENO, JN ;
REYES, RR ;
BOOTA, AM ;
THOMPSON, LM ;
CLEARY, TJ ;
OLDHAM, SA ;
SALDANA, MJ ;
LAI, SH .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (03) :184-190
[10]   AN OUTBREAK OF TUBERCULOSIS CAUSED BY MULTIPLE-DRUG-RESISTANT TUBERCLE-BACILLI AMONG PATIENTS WITH HIV-INFECTION [J].
FISCHL, MA ;
UTTAMCHANDANI, RB ;
DAIKOS, GL ;
POBLETE, RB ;
MORENO, JN ;
REYES, RR ;
BOOTA, AM ;
THOMPSON, LM ;
CLEARY, TJ ;
LAI, SH .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (03) :177-183